Literature DB >> 22014091

Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.

M Ziemer1, S H Kardaun, Y Liss, M Mockenhaupt.   

Abstract

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions with high morbidity and mortality. Some expressions of lupus erythematosus (LE) may cause enormous difficulties in differentiating them from SJS and TEN by showing large areas of sheet-like epidermal necrosis.
OBJECTIVE: To evaluate clinically and histopathologically probable or definite cases of SJS/TEN with a history of systemic or other LE [(S)LE].
METHODS: This was a retrospective analysis of validated cases of SJS/TEN with a history of (S)LE, based on a large population-based national registry.
RESULTS: Among 1366 patients with SJS/TEN, 17 with a sufficiently documented history of (S)LE and representative histological material could be identified, suggesting a considerable over-representation of LE in patients with SJS/TEN. Eight of these showed clinically and/or histopathologically some LE-characteristic features interfering with the diagnosis of SJS/TEN. Differentiation could be elaborated on clinical and histopathological grounds: four patients were classified as SJS/TEN with a preceding (S)LE exacerbation and/or LE-typical histopathological features, and four as 'TEN-like' (S)LE.
CONCLUSION: Most patients with SJS/TEN and a history of (S)LE demonstrate clinical and histopathological properties allowing clear differentiation. However, occasionally acute cutaneous manifestations of (S)LE and SJS/TEN can be phenotypically similar, caused by extensive epidermal necrosis. Although no feature by itself is conclusive, a combination of recent (S)LE exacerbation, evident photodistribution, annular lesions and absent or only mild focal erosive mucosal involvement may favour LE over SJS/TEN clinically. Histopathologically, in particular, junctional vacuolar alteration, and the presence of solitary necrotic keratinocytes at lower epidermal levels, combined with moderate to dense periadnexal and perivascular lymphocytic infiltrates with a variable presence of melanophages, and mucin point to a LE-related origin.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2012        PMID: 22014091     DOI: 10.1111/j.1365-2133.2011.10705.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome.

Authors:  Irma L Vázquez-Sanabria; Rogelio Mercado-Seda; Noemí Varela-Rosario; Luis M Vilá
Journal:  BMJ Case Rep       Date:  2015-07-22

Review 2.  Bullous lesions in a patient with systemic lupus erythematosus.

Authors:  Jennifer S Ranario; Jennifer L Smith
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

3.  Stevens-Johnson Syndrome-Like Skin Lesions in a Patient with Juvenile Systemic Lupus Erythematosus.

Authors:  Hee Won Jang; Jung Jin Shin; Jae Beom Park; Sang Wook Son
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

Review 4.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

Review 5.  Toxic epidermal necrolysis in a child with lupus-associated pancreatitis.

Authors:  Stevic Marija; Budic Ivana; Ristic Nina; Nenadic Dragan; Bokun Zlatko; Jovanovic Branislav; Pejanovic Jelena; Simic Dusica
Journal:  Rheumatol Int       Date:  2017-02-26       Impact factor: 3.580

Review 6.  Bullous Drug Reactions.

Authors:  Maja Mockenhaupt
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

7.  Toxic Epidermal Necrolysis-Like Lesions and Systemic Lupus Erythematosus Possibly Triggered by Sulfasalazine.

Authors:  Simon Krabbe; Cigdem Gül; Bjarne Andersen; Niels Tvede
Journal:  Case Rep Rheumatol       Date:  2016-07-12

Review 8.  Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions.

Authors:  Robert A Case; Vishal Patel; Carolina Mejia-Otero; Alan E Siroy; Divya C Patel
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

Review 9.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

10.  Blisters and Loss of Epidermis in Patients With Lupus Erythematosus: A Clinicopathological Study of 22 Patients.

Authors:  Carine Merklen-Djafri; Didier Bessis; Camille Frances; Nicolas Poulalhon; Sébastien Debarbieux; Nadège Cordel; Dan Lipsker
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.